Is it just me or does "The Street" have a real hard on for Avanir. First, that dude publishes an article and says the drug won't get approved. Guess what, he is wrong. Next, the dude publishes an article that says, yeah I was wrong but the company still blows. The the street publishes the Insider buying report (referring to Yahoo Business) last Friday and Avenir is listed as having insiders selling. Then, in case we didn't get that, they post another Insider buying report with Avenir listed on it again. I am thinking "The Street" doesn't like being wrong. Doesn't Cramer own this?
